| Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine LB Sheiner, DR Stanski, S Vozeh, RD Miller, J Ham Clinical Pharmacology & Therapeutics 25 (3), 358-371, 1979 | 1479 | 1979 |
| The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. TD Egan, HJ Lemmens, P Fiset, DJ Hermann, KT Muir, DR Stanski, ... Anesthesiology 79 (5), 881-892, 1993 | 834 | 1993 |
| EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. JC Scott, KV Ponganis, DR Stanski Anesthesiology 62 (3), 234-241, 1985 | 676 | 1985 |
| Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. JC Scott, DR Stanski Journal of Pharmacology and Experimental Therapeutics 240 (1), 159-166, 1987 | 571 | 1987 |
| Comparative pharmacology of the ketamine isomers: studies in volunteers PF White, J Schüttler, A Shafer, DR Stanski, Y Horai, AJ Trevor BJA: British Journal of Anaesthesia 57 (2), 197-203, 1985 | 471 | 1985 |
| Absorption characteristics of transdermally administered fentanyl. JR Varvel, SL Shafer, SS Hwang, PA Coen, DR Stanski Anesthesiology 70 (6), 928-934, 1989 | 440 | 1989 |
| Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. JC Scott, JE Cooke, DR Stanski Anesthesiology 74 (1), 34-42, 1991 | 420 | 1991 |
| Monitoring depth of anesthesia DR Stanski Anesthesia, 1109-1113, 2000 | 363 | 2000 |
| Absorption and bioavailability of oral transmucosal fentanyl citrate. JB Streisand, JR Varvel, DR Stanski, L Le Maire, MA Ashburn, BI Hague, ... Anesthesiology 75 (2), 223-229, 1991 | 348 | 1991 |
| A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect V Billard, PL Gambus, N Chamoun, DR Stanski, SL Shafer Clinical Pharmacology & Therapeutics 61 (1), 45-58, 1997 | 338 | 1997 |
| Kinetics of intravenous and intramuscular morphine DR Stanski, DJ Greenblatt, E Lowenstein Clinical Pharmacology & Therapeutics 24 (1), 52-59, 1978 | 338 | 1978 |
| Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. ME Ausems, CC Hug Jr, DR Stanski, AG Burm Anesthesiology 65 (4), 362-373, 1986 | 312 | 1986 |
| Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development C Peck Carl, Z Benet Leslie, E Robert, G John, H Rodman John, J Jerome, ... Clin. Pharmacol. Ther. 51, 465-474, 1992 | 306 | 1992 |
| Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. PO Maitre, S Vozeh, J Heykants, DA Thomson, DR Stanski Anesthesiology 66 (1), 3-12, 1987 | 295 | 1987 |
| Hemodynamic response to induction and intubation. Propofol/fentanyl interaction. V Billard, F Moulla, JL Bourgain, A Megnigbeto, DR Stanski Anesthesiology 81 (6), 1384-1393, 1994 | 270 | 1994 |
| Pharmacokinetic/pharmacodynamic modeling in drug research and development H Derendorf, LJ Lesko, P Chaikin, WA Colburn, P Lee, R Miller, R Powell, ... The Journal of Clinical Pharmacology 40 (12), 1399-1418, 2000 | 256 | 2000 |
| Linearity of pharmacokinetics and model estimation of sufentanil E Gepts, SL Shafer, F Camu, DR Stanski, R Woestenborghs, A Van Peer, ... The Journal of the American Society of Anesthesiologists 83 (6), 1194-1204, 1995 | 254 | 1995 |
| The effect of increasing age on thiopental disposition and anesthetic requirement. TD Homer, DR Stanski Anesthesiology 62 (6), 714-724, 1985 | 245 | 1985 |
| A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam PO Maitre, M Bührer, D Thomson, DR Stanski Journal of pharmacokinetics and biopharmaceutics 19 (4), 377-384, 1991 | 222 | 1991 |
| Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man J Schüttler, DR Stanski, PF White, AJ Trevor, Y Horai, D Verotta, ... Journal of pharmacokinetics and biopharmaceutics 15 (3), 241-253, 1987 | 210 | 1987 |
